Basic Information
Basic information for FTX-265-105aa
Peptide Name FTX-265-105aa
Genome Position chrX:74203566-74203880[-]
Species Human
Peptide Sequence MSTSISPLYPSLLVWISRYTTASSCSPSLGAGPAGTPRRSPSTVAAAPQRWPPPLTLRWHTSPYPPESPSTCCLYRQALGSWPLALCLQHCHLHVDWEPHSPRTC
Peptide Length 105
Unique No (FTX-202-105aa,FTX-210-105aa,FTX-218-105aa,FTX-223-105aa,FTX-224-105aa,FTX-228-105aa,FTX-229-105aa,FTX-231-105aa,FTX-233-105aa,FTX-236-105aa,FTX-238-105aa,FTX-241-105aa,FTX-245-105aa,FTX-257-105aa,FTX-261-105aa,FTX-264-105aa,FTX-266-105aa,FTX-268-105aa)
Grand Average of Hydropathicity -0.2629
Relative Molecular Mass 13394.96
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000665313;FTX-265
Transcript Length 1790
Coding Ability 0.5497
DNA Sequence Corresponding to Peptide ATGTCAACCTCAATTTCTCCTCTTTATCCTTCTCTCCTGGTTTGGATTTCAAGGTATACCACCGCATCTTCCTGCTCCCCTAGTCTGGGTGCAGGTCCTGCAGGTACACCTCGGCGAAGCCCAAGTACAGTAGCAGCAGCACCTCAAAGGTGGCCTCCTCCTCTGACACTGAGGTGGCATACTTCTCCTTACCCACCTGAATCACCGAGTACATGTTGCTTGTACCGTCAGGCTCTTGGTTCTTGGCCCCTGGCCCTATGCCTGCAACACTGTCACCTGCACGTGGATTGGGAACCACATAGCCCCCGGACCTGC
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :